Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro. - Wikidata - awgldk - TriplyDB

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

http://www.wikidata.org/entity/Q33231599

about

Effects of Traditional Chinese Medicinal Plants on Anti-insulin Resistance Bioactivity of DXMS-Induced Insulin Resistant HepG2 Cells Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy Secondary metabolites of the genus Astragalus: structure and biological-activity update.Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.Anti-inflammatory cycloartane-type saponins of Astragalus membranaceus.Macropinocytosis contributes to the macrophage foam cell formation in RAW264.7 cells.Radix astragali (huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes.Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation.

P2860

Q33953672-28741CB8-3216-4D8B-BCBB-39781E9EF0DE Q34837833-CB7CC9E5-C830-4A97-801C-BA0236475650 Q38115274-B9E6B521-B12F-47A2-8CC0-2D78DD0A4293 Q38782659-1138FA1B-C864-458B-9316-DF4024DB76B3 Q39175718-34302FFD-3E42-4061-9EAB-CD0C1AD6431F Q39804195-6DE23D80-6B0E-4FA5-A1F7-2349C586B150 Q39819187-69ADB260-EA33-4887-B617-71F7F593E63B Q47807082-58EE3679-E866-4C25-9680-A0B64AF6F143 Q53689698-ACA43BB4-B072-4F56-B719-17930CF9EF4D

P2860

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

http://www.wikidata.org/entity/Q33231599

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@ast

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@en

type

label

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@ast

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@en

prefLabel

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@ast

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@en

P1433

Q33231599-9A049199-2C7F-42A7-ACB5-E9DBC33C0F99

P1476

Q33231599-283253BB-6640-49EF-B9D6-A5036CDF3A3E

P2093

Q33231599-00870E4B-8C1F-4897-97DF-D87196F035F1

Q33231599-2C666A45-2103-4FAF-B783-787F7519D5A9

Q33231599-3B6022CC-9DB9-4C80-ADE9-6DBF8A190C84

Q33231599-6BE11DDE-1C82-458A-9CBB-769937AFF328

Q33231599-BD1A4914-92BB-49A6-81AA-99F3E0C9333F

P2860

Q33231599-0EB2CCA5-4F70-4F27-8791-7B890AAEB4B4

Q33231599-2A726E5A-AD89-4FCF-A659-C5B644EDC733

Q33231599-39149184-4B99-45E9-BF88-4E5AC1F2373C

Q33231599-4650F89F-C4C4-4538-8E8C-DC4694CEF442

Q33231599-5074BF53-E019-47B0-9488-EA6E2091A9B9

Q33231599-69830A51-D47A-4FBB-B928-D044847802A0

Q33231599-71181F25-DE08-4A31-B1D5-1A38CE8B98D4

Q33231599-B5178696-04EF-4801-837A-EC1E2C2FED72

Q33231599-C8891547-9B23-4ED6-AF0F-240340053FCD

Q33231599-E400E48A-73F1-421F-8783-D1BCA8696373

P2888

Q33231599-229AF0F0-6200-4A90-846E-3AED463244CA

P304

Q33231599-1D3809BE-3350-4209-97AC-9099C91AA6FC

P31

Q33231599-92D2BBC8-43B0-4BFE-A362-D057AF7AEFC2

P356

Q33231599-734D5A8E-5936-4F7C-A48D-85A3744A34C0

P433

Q33231599-E5F7BC88-7DA1-4F11-BF51-51923C7696BD

P478

Q33231599-AEB33B54-85A5-46C6-83CE-1FB8135821A5

P577

Q33231599-6708980A-F6A9-453C-A8B8-147D62A020A6

P5875

Q33231599-8131A318-2D4F-47BE-8FFB-8EB0AB44131C

P6179

Q33231599-23BC99C5-0AC7-47C8-AD2E-FD8B1AAAFDF8

P698

Q33231599-44ABF3C3-78AE-4F6D-9F7A-56FDF91E28D2

P921

Q33231599-31190A4B-3DBE-42F2-BBE2-A94348A86A39

P356

J.1745-7254.2006.00243.X

P1433

Acta Pharmacologica Sinica

P1476

Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.

@en

P2093

Ming-en Xu

http://www.w3.org/2001/XMLSchema#string

Shang-zhi Xiao

http://www.w3.org/2001/XMLSchema#string

Xiao-xiang Zheng

http://www.w3.org/2001/XMLSchema#string

Yang Ou-Yang

http://www.w3.org/2001/XMLSchema#string

Yong-hong Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Troglitazone and related compounds: therapeutic potential beyond diabetes.

Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.

An overview on biological mechanisms of PPARs.

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.

A major health hazard: the metabolic syndrome.

Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals.

Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes.

Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.

P2888

j.1745-7254.2006.00243.x

P304

229-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1745-7254.2006.00243.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7360550

http://www.w3.org/2001/XMLSchema#string

P6179

1000553415

http://www.w3.org/2001/XMLSchema#string

P698

16412274

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome